US 11963982
CRISPR/RNA-guided nuclease systems and methods
granted A61KA61K35/18
Quick answer
US patent 11963982 (CRISPR/RNA-guided nuclease systems and methods) held by Editas Medicine, Inc. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/18